SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 225 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3 | -72.7% | 8,316 | -38.4% | 0.00% | – |
| Q4 2022 | $11 | -100.0% | 13,492 | -93.6% | 0.00% | -100.0% |
| Q3 2022 | $330,000 | +118.5% | 209,892 | +179.2% | 0.01% | +66.7% |
| Q2 2022 | $151,000 | -47.8% | 75,180 | -39.5% | 0.00% | 0.0% |
| Q1 2022 | $289,000 | +65.1% | 124,166 | +229.6% | 0.00% | 0.0% |
| Q4 2021 | $175,000 | -73.0% | 37,672 | -55.5% | 0.00% | -82.4% |
| Q3 2021 | $647,000 | +824.3% | 84,744 | +1069.0% | 0.02% | +750.0% |
| Q2 2021 | $70,000 | -83.1% | 7,249 | -85.5% | 0.00% | -71.4% |
| Q1 2021 | $413,000 | +778.7% | 49,955 | +613.8% | 0.01% | +600.0% |
| Q4 2020 | $47,000 | -98.5% | 6,998 | -97.5% | 0.00% | -97.1% |
| Q3 2020 | $3,086,000 | +462.1% | 276,714 | +216.6% | 0.03% | +47.8% |
| Q2 2020 | $549,000 | – | 87,412 | +90015.5% | 0.02% | – |
| Q4 2019 | $0 | -100.0% | 97 | -99.3% | 0.00% | -100.0% |
| Q3 2019 | $30,000 | +2900.0% | 13,900 | +4726.4% | 0.00% | – |
| Q2 2019 | $1,000 | – | 288 | +188.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 100 | -99.5% | 0.00% | -100.0% |
| Q3 2018 | $91,000 | +9000.0% | 20,749 | +20649.0% | 0.01% | – |
| Q1 2018 | $1,000 | -80.0% | 100 | -96.5% | 0.00% | – |
| Q3 2017 | $5,000 | -66.7% | 2,872 | -62.2% | 0.00% | -100.0% |
| Q2 2017 | $15,000 | +400.0% | 7,596 | +968.4% | 0.00% | – |
| Q1 2017 | $3,000 | -25.0% | 711 | -20.6% | 0.00% | – |
| Q4 2016 | $4,000 | – | 895 | +17800.0% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 5 | -99.9% | 0.00% | -100.0% |
| Q1 2016 | $19,000 | +216.7% | 3,485 | +420.1% | 0.00% | +200.0% |
| Q4 2015 | $6,000 | +200.0% | 670 | +235.0% | 0.00% | – |
| Q3 2015 | $2,000 | -95.5% | 200 | -91.9% | 0.00% | -100.0% |
| Q2 2015 | $44,000 | +57.1% | 2,469 | +1.2% | 0.00% | +33.3% |
| Q1 2015 | $28,000 | +1300.0% | 2,440 | +442.2% | 0.00% | – |
| Q3 2014 | $2,000 | -66.7% | 450 | -45.1% | 0.00% | -100.0% |
| Q2 2014 | $6,000 | -77.8% | 819 | -61.1% | 0.00% | -66.7% |
| Q1 2014 | $27,000 | – | 2,106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |